Skip to main content
Article
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
Cancer Research (1998)
  • Robert J. Morgan, City of Hope National Medical Center
  • Edward M. Newman, City of Hope National Medical Center
  • James H. Doroshow, City of Hope National Medical Center
  • Kathryn McGonigle, City of Hope National Medical Center
  • Kim Margolin, City of Hope National Medical Center
  • James Raschko, City of Hope National Medical Center
  • Warren Chow, City of Hope National Medical Center
  • George Somlo, City of Hope National Medical Center
  • Lucille Leong, City of Hope National Medical Center
  • Merry Tetef, City of Hope National Medical Center
  • Stephen Shibata, City of Hope National Medical Center
  • Victor Hamasaki, City of Hope National Medical Center
  • Mary Carroll, City of Hope National Medical Center
  • Steven Vasilev, City of Hope National Medical Center
  • Steven Akman, City of Hope National Medical Center
  • Paul Coluzzi, City of Hope National Medical Center
  • Lawrence Wagman, City of Hope National Medical Center
  • Jeff Longmate, City of Hope National Medical Center
  • Benjamin Paz, City of Hope National Medical Center
  • Yun Yen, City of Hope National Medical Center
  • Robert Klevecz, City of Hope National Medical Center
Publication Date
July 1, 1998
Citation Information
Robert J. Morgan, Edward M. Newman, James H. Doroshow, Kathryn McGonigle, et al.. "Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis." Cancer Research Vol. 58 Iss. 13 (1998) p. 2793 - 2800
Available at: http://works.bepress.com/steven-vasilev/23/